MwanzoDMYD-B • STO
add
Diamyd Medical AB
Bei iliyotangulia
kr 18.16
Bei za siku
kr 17.88 - kr 18.70
Bei za mwaka
kr 7.65 - kr 25.00
Thamani ya kampuni katika soko
1.83B SEK
Wastani wa hisa zilizouzwa
elfu 226.52
Uwiano wa bei na mapato
-
Mgao wa faida
-
Ubadilishanaji wa msingi
STO
Habari za soko
Fedha
Taarifa ya Mapato
Mapato
Mapato halisi
| (SEK) | Ago 2024info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato | elfu 19.00 | -74.32% |
Matumizi ya uendeshaji wa biashara | 51.15M | 40.41% |
Mapato halisi | -49.74M | -32.60% |
Kiwango cha faida halisi | elfu -261.79 | -416.43% |
Mapato kwa kila hisa | — | — |
EBITDA | -50.48M | -40.02% |
Asilimia ya kodi ya mapato | — | — |
Taarifa ya Hali ya Kifedha
Jumla ya mali
Jumla ya dhima
| (SEK) | Ago 2024info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Uwekezaji wa pesa taslimu na vipindi vifupi | 132.37M | 3.79% |
Jumla ya mali | 217.04M | 5.46% |
Jumla ya dhima | 71.12M | 95.32% |
Jumla ya hisa | 145.92M | — |
hisa zilizosalia | 104.09M | — |
Uwiano wa bei na thamani | 12.44 | — |
Faida inayotokana na mali | -55.84% | — |
Faida inayotokana mtaji | -76.10% | — |
Mtiririko wa pesa
Mabadiliko halisi ya pesa taslimu
| (SEK) | Ago 2024info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato halisi | -49.74M | -32.60% |
Pesa kutokana na shughuli | -29.16M | 15.53% |
Pesa kutokana na uwekezaji | 18.79M | 886.03% |
Pesa kutokana na ufadhili | elfu -838.00 | -100.97% |
Mabadiliko halisi ya pesa taslimu | -10.27M | -120.46% |
Mtiririko huru wa pesa | -18.28M | 27.58% |
Kuhusu
Diamyd Medical AB is a small biotechnology company headquartered in Stockholm, Sweden that focuses on immune modifying therapies for diabetes. The company is developing two products.
The company is headquartered in Stockholm, and maintains a manufacturing facility in Umeå. Wikipedia
Afisa Mkuu Mtendaji (CEO)
Ilianzishwa
1984
Tovuti
Wafanyakazi
28
